| Structure | Chemical Name | CAS | MF |
|
DDMAU
|
|
C25H51NO2
|
|
DECAV protocol
|
|
|
|
|
Decay Accelarating Factor (DAF), CD55, Hematopoitic & non-hematopoetic Cell, Cl.: 143-30, Mab anti-Human
|
|
|
|
DEBLOCKING REAGENT
|
|
C3H4Cl4O2
|
|
|
DEBLOCK SOLUTION
|
|
|
|
Dichloromethane
|
75-09-2
|
CH2Cl2
|
|
|
DEA (WEAK ANION), 10ML LRC COLUMN 100 MG
|
|
|
|
|
Decay Accelarating Factor (DAF), CD55, Hematopoitic & non-hematopoetic Cell, Cl.: 143-30, Mab anti-Human, RPE
|
|
|
|
|
DEA (WEAK ANION), 10ML LRC COLUMN 500 MG
|
|
|
|
|
Decay Accelarating Factor (DAF), CD55, Hematopoitic & non-hemat. Cell, Clone: BRIC-216, Mab anti-Human
|
|
|
|
|
Decay Accelarating Factor, CD55,Hematopoeitic and non-Hematopoietic Cells,gp 70,Cl.: BRIC 110,Mab anti-Hu.
|
|
|
|
|
Decay Accelarating Factor, CD55, Hematopoitic & non-hematopoetic Cell, Cl: BRIC216, Mab anti-Hu., Blocks, flw/IP/WB
|
|
|
|
|
Decay Accelarating Factor, CD55, Hematopoitic & non-hematopoetic Cell, Clone: 67, Mab anti-Human, RPE, flow
|
|
|
|
|
Decay Accelarating Factor (DAF), CD55, Hematopoitic & non-hematopoetic Cell, Cl.: 143-30, Mab anti-Human, RPE/Cy5
|
|
|
|
|
Decay Accelarating Factor (DAF), CD55, Hematopoitic & non-hematopoetic Cell, Cl.: 143-30, Mab anti-Human, FITC
|
|
|
|
|
Decay Accelarating Factor, CD55, GPI-linked 70kD, Clone: MEM-118, Mab anti-Human
|
|
|
|
|
Decay Accelarating Factor, CD55, Hematopoitic & non-hematopoetic Cell, Clone: 67, Mab anti-Human, flow
|
|
|
|
|
Decay Accelarating Factor, CD55,Hematopoeitic and non-Hematopoietic Cells,gp 70,Cl.: BRIC 110,Mab anti-Hu., FITC
|
|
|
|
|
DEC-205,CLONE:11A10,MABANTI-HUMAN:PARAFFIN
|
|
|
|
|
DEC1 (Deleted in Esophageal Cancer 1), ~20kD, Goat anti-Human, WB
|
|
|
|
Debneyol
|
99694-82-3
|
C15H26O2
|
|
|
DEB-M protocol
|
|
|
|
|
D,DM,CZ,TMTD,NS,ZDEC,DPG,PVI,6PPD,1PPD,etc.
|
|
|
|
|
9-deazahypoxanthine
|
|
|
|
3-Deaza-2-aminopurine
|
2603-29-4
|
C6H6N4
|
|
4-[2’-(7’’-Deazaguanine)ethyl]benzoic Acid N-Hydroxysuccinimide Ester
|
204257-65-8
|
C19H17N5O5
|
|
7-Deaza-2'-deoxy-7-iodoadenosine
|
908130-61-0
|
C11H13IN4O3
|
|
|
7-Deaza-2'-deoxy-2'-fluoroguanosine
|
|
C11H14FN4O4
|
|
7-Deaza-2'-C-ethynyladenosine
|
1044589-82-3
|
C13H14N4O4
|
|
|
7-Deaza-2'-deoxy-5'-O-DMT-N2-isobutyrylguanosine
|
|
C36H38N4O7
|
|
7-Deaza-2,3-dideoxyadenosine Suppliers
|
40627-30-3
|
C11H14N4O2
|
|
|
7-deaza-R34
|
|
|
|
|
3-deaza-5'-noraristeromycin
|
|
|
|
|
7-Deaza-2'-deoxy-D-inosine
|
|
|
|
9-deaza-9-(3-thienylmethyl)guanine
|
132138-76-2
|
C11H10N4OS
|
|
|
7-deazaxanthine
|
|
|
|
|
7-Deaza-2',3'-dideoxy-D-guanosine
|
|
|
|
3-deazacytidine
|
28307-19-9
|
C10H14N2O5
|
|
7-DEAZA-2'-DEOXYINOSINE, [8-3H(N)]-
|
|
C11H12N3O4T
|
|
7-DEAZAGUANOSINE, [8-3H(N)]-
|
|
C11H13N4O5T
|
|
8-deazafolic acid
|
51989-25-4
|
C20H20N6O6
|
|
|
7-deaza-dGTP
|
|
|
|
|
7-DEAZA-SS-D-2'',3''-DIDEOXYGUANOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
7-DEAZA-BETA-D-2',3'-DIDEOXYGUANOSINE
|
|
C11H14N4O3
|
|
|
7-DEAZA-2''-DEOXYINOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
7-DEAZA-SS-D-2'',3''-DIDEOXYADENOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
7-deaza-8-bromo-cyclic ADP-ribose
|
|
|
|
3-deazaguanosine
|
56039-11-3
|
C11H14N4O5
|
|
|
7-DEAZA-7-IODO-2''-DEOXYGUANOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
7-DEAZA-7-IODO-2''-DEOXYADENOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
7-DEAZA-6-METHOXY-2''-DEOXYGUANOSINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
|
|
|
|
|
9-DEAZA-2''-DEOXYGUANOSINE
|
|
|
|
5-deazaaminopterin
|
80360-09-4
|
C20H21N7O5
|
|
7-DEAZA-2-MERCAPTO-HYPOXANTHINE
|
|
C6H5N3OS
|
|
7-deaza-9-(2-hydroxy-3-nonyl)adenine
|
103298-51-7
|
C15H24N4O
|
|
3-deazacyclopentenylcytosine
|
130378-89-1
|
C11H13NO5
|
|
|
7-DEAZA-2',3'-DIDEOXYADENOSINE, [8-3H(N)]-
|
|
C11H13N4O2T
|
|
|
7-DEAZAINOSINE, [8-3H(N)]-
|
|
C11H12N3O5T
|
|
|
7-Deaza-2',3'-dideoxy-D-adenosine
|
|
|
|
8-deazahomofolic acid
|
111113-73-6
|
C21H22N6O6
|
|
|
7-Deaza-2'-deoxy-7-iodo-D-guanosine
|
|
|
|
DEAZAPURINE
|
271-70-5
|
C6H5N3
|
|
7-DEAZAGUANOSINE
|
102731-45-3
|
C11H14N4O5
|
|
|
DCVP-1-asp protocol
|
|
|
|
3-deaza-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine
|
137427-72-6
|
C10H13N4O4P
|
|
7-DEAZA-2'-DEOXYXANTHOSINE
|
96022-82-1
|
C11H13N3O5
|
|
5-deazaflavin 4,5-epoxide
|
86889-50-1
|
C18H21N3O7
|
|
7-deaza-2'-deoxyinosine triphosphate
|
136120-28-0
|
C11H16N3O13P3
|
|
3-deaza-6-azauridine
|
56707-91-6
|
C9H12N2O6
|
|
3-deazauridine 5'-triphosphate
|
54267-16-2
|
C10H16NO15P3
|
|
7-DEAZAGUANOSINE-5'-TRIPHOSPHATE LITHIUM SALT
|
|
C11H13Li4N4O14P3
|
|
7-DEAZAGUANOSINE
|
62160-23-0
|
C11H14N4O5
|
|
3-DEAZAADENOSINE, [3H]-
|
|
C11N4O4T14
|
|
1-deazaadenosine
|
14432-09-8
|
C11H14N4O4
|
|
7-DEAZA-6-METHOXY-2'-DEOXYGUANOSINE, [8-3H(N)]-
|
|
C12H15N4O4T
|
|
7-DEAZAADENOSINE, [3H]-
|
|
C11H13N4O4T
|
|
3-DEAZA-DA CEP
|
666257-76-7
|
C48H53N6O7P
|
|
Deaza-Aminopterin
|
18921-68-1
|
C21H22N6O5
|
|
|
7-Deaza-2'-deoxynucleoside-5'-triphosphate
|
|
|
|
|
7-deaza cyclic adenosine 5'-diphosphate ribose
|
|
|
|
7-DEAZA-2'-DEOXYADENOSINE-5'-TRIPHOSPHATE LITHIUM SALT
|
|
C11H16LiN4O12P3
|
|
3-DEAZANEPLANOCIN, [3H]-
|
|
C12N4O3T16
|
|
|
7-DEAZA-2'-DEOXYADENOSINE, [8-3H(N)]-
|
|
C11H13N4O3T
|
|
1-deaza-FMN
|
70805-82-2
|
C18H22N3O9P
|
|
|
DdMEK1
|
|
|
|
3-deaza-2'-deoxycytidine
|
29868-19-7
|
C10H14N2O4
|
|
7-DEAZA-7-CARBAMOYLADENOSINE HYDRATE
|
|
C12H17N5O6
|
|
9-deazainosine
|
89458-19-5
|
C11H13N3O5
|
|
5-deazariboflavin
|
19342-73-5
|
C18H21N3O6
|
|
5-deazamethotrexate
|
80360-10-7
|
C21H23N7O5
|
|
11-deazahomofolic acid
|
119770-54-6
|
C21H22N6O6
|
|
7-deazainosine
|
2862-16-0
|
C11H13N3O5
|
|
7-DEAZAADENOSINE-5'-TRIPHOSPHATE LITHIUM SALT
|
|
C11H13Li4N4O13P3
|
|
3-deaza-2'-deoxyguanosine
|
83587-63-7
|
C11H14N4O4
|
|
3-deaza-4-deoxyuridine
|
5116-37-0
|
C10H13NO5
|
|
7-DEAZA-2'-DEOXYXANTHOSINE CEP
|
676456-10-3
|
C41H48N5O8P
|
|
7-DEAZA-7-IODO-2'-DEOXYGUANOSINE
|
172163-62-1
|
C11H13IN4O4
|
|
5-deazalumiflavin
|
61696-29-5
|
C14H13N3O2
|
|
Pyrrolo[2,3-d]pyrimidin-4-ol
|
3680-71-5
|
C6H5N3O
|
|
3-DEAZAARISTEROMYCIN, [8-3H(N)]
|
|
C12H15N4O3T
|